Anti-FLEX: Flexed Levering of Gluteal Vessels

February 27, 2020 updated by: University of South Florida

Anti-FLEX: Flexed Levering of Gluteal Vessels on OR Table May Lead to Extreme Danger During Gluteal Augmentation With Lipoaspirate, a Radio-graphically Studied Position of Superior and Inferior Gluteal Vessels During Flexion of OR Table or "Jack-knife" Position, Danger Zone.

The purpose of this study is to evaluate the effect of the gluteal vasculature in the prone and jackknife positions.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This is a prospective collection of contrast-enhanced CT images of healthy female volunteers in prone and jackknife positions in order to determine if position impacts gluteal venous vasculature.

Study Type

Observational

Enrollment (Actual)

11

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Tampa, Florida, United States, 33606
        • Tampa General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Healthy volunteers who will undergo contrast-enhanced CT imaging of the gluteal venous vasculature in the prone and jackknife positions

Description

Inclusion Criteria:

  • Females age 20 - 50 years
  • BMI between 20 - 35 kg/m2
  • Willingness and ability to provide written informed consent
  • Willingness and ability to comply with all study procedures
  • Interested or planning to have a gluteal augmentation

Exclusion Criteria:

  • Males
  • Females age < 20 or >= 51 years
  • BMI between < 20 or > 35 kg/m2
  • Prior gluteal augmentation surgery
  • Any prior gluteal soft tissue filler
  • Known or suspected history of immediate or delayed hypersensitivity (including but not limited to hives, anaphylactoid or cardiovascular reactions, laryngeal edema, and bronchospasm) to iodine or any iodinated contrast medium
  • Documented history of chronic kidney disease that contraindicates the use of contrast dye
  • Pregnant
  • Currently breast-feeding
  • Any reason (in addition to those listed above) that, in the opinion of the principal investigator, precludes full participation in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy volunteers
Healthy volunteers who will undergo contrast-enhanced CT imaging of the gluteal venous vasculature in the prone and jackknife positions
Contrast-enhanced CT imaging of the pelvis in prone and jackknife positions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean difference of position of the gluteal venous vasculature in relation to the skin
Time Frame: at CT scan visit
Between the Prone position and the Jackknife position
at CT scan visit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean difference of vessel diameter of the gluteal venous vasculature
Time Frame: at CT scan visit
Between the Prone position and the Jackknife position
at CT scan visit
Mean difference of the danger zone
Time Frame: at CT scan visit
Between the Prone position and the Jackknife position
at CT scan visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Connor Barnes, MD, University of South Florida

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 3, 2018

Primary Completion (Actual)

November 21, 2018

Study Completion (Actual)

January 13, 2020

Study Registration Dates

First Submitted

September 14, 2017

First Submitted That Met QC Criteria

September 14, 2017

First Posted (Actual)

September 18, 2017

Study Record Updates

Last Update Posted (Actual)

February 28, 2020

Last Update Submitted That Met QC Criteria

February 27, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00031729

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on CT imaging

Subscribe